WEBINAR

Advanced PGx: Drug-Drug Interactions & Polypharmacy

Join our live CPD webinar for practical insights into how pharmacogenomics (PGx) can support safer, more personalised mental health prescribing—especially in patients with ADHD and those on complex medication regimens.

22nd July 202522nd July 2025

Time: 12:30pmTime: 12:30pm

Duration: 45 minsDuration: 45 mins

Audience

DoctorsPhysiatrist

Mental Health PractitionersMental Health Practitioners

Sign Up
Advanced PGx: Drug-Drug Interactions & Polypharmacy

Managing Polypharmacy & DDIs in Psychiatric Care

For mental health professionals, managing patients on multiple medications—such as antidepressants, antipsychotics, and ADHD treatments—requires careful navigation of drug-drug interactions (DDIs). These can reduce efficacy, cause toxicity, or lead to unpredictable side effects.

This advanced CPD webinar explores how PGx testing helps clinicians understand how metabolic enzymes (e.g., CYP2D6, CYP3A4) affect drug processing, providing tools to reduce adverse drug reactions and personalise treatment in psychiatry and neurodevelopmental care.

Whether you're treating ADHD, anxiety, or mood disorders, this session will help you apply pharmacogenomic insights in real-world clinical settings.

Polypharmacy Risk

Learn how polypharmacy in mental health can increase DDI risks and adverse drug outcomes.

PGx Application

Explore how PGx guides safer prescribing across multiple genetically influenced enzymatic pathways.

Case-Based Learnings

Review case studies from psychiatry and ADHD management with practical applications.

Personalised Prescribing

Understand how to individualise treatment based on metabolism, drug transport, and patient genetics.

Live Q&A

Bring your questions—our experts will answer them live during the session.

CPD Certificate

Receive a certificate of attendance for your CPD portfolio.

Meet the Speakers

Prince Agyirey-Kwakye

Chief Scientific Officer

Simon Dean

CMO

LinkedIn

Register Now

Join our live CPD webinar for practical insights into how pharmacogenomics (PGx) can support safer, more personalised mental health prescribing—especially in patients with ADHD and those on complex medication regimens.

Stay In The Loop

We'd like to send you occasional updates about this webinar and other services. Please confirm your consent to receive these communications by checking the box below.

I consent to receive communications about this webinar and other related content from AttoDiagnostics. I understand that I can unsubscribe at any time.